Moran Wealth Management LLC Invests $2.42 Million in Addus HomeCare Corporation $ADUS

Moran Wealth Management LLC bought a new stake in Addus HomeCare Corporation (NASDAQ:ADUS) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 20,504 shares of the company’s stock, valued at approximately $2,419,000.

A number of other large investors have also added to or reduced their stakes in ADUS. State of Wyoming acquired a new position in Addus HomeCare in the 2nd quarter worth $47,000. Raymond James Financial Inc. purchased a new stake in shares of Addus HomeCare during the second quarter worth about $61,000. Blue Trust Inc. increased its position in shares of Addus HomeCare by 42.9% during the third quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $63,000 after acquiring an additional 161 shares during the last quarter. CWM LLC lifted its stake in shares of Addus HomeCare by 25.3% in the second quarter. CWM LLC now owns 554 shares of the company’s stock worth $64,000 after acquiring an additional 112 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in Addus HomeCare by 560.0% in the second quarter. EverSource Wealth Advisors LLC now owns 561 shares of the company’s stock valued at $65,000 after purchasing an additional 476 shares during the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the company. Barclays lifted their price objective on Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a report on Tuesday, November 4th. TD Cowen lifted their price target on shares of Addus HomeCare from $139.00 to $140.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Cowen reaffirmed a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, October 8th. Finally, BMO Capital Markets began coverage on shares of Addus HomeCare in a research note on Thursday, November 13th. They issued a “market perform” rating and a $120.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Addus HomeCare has an average rating of “Moderate Buy” and a consensus price target of $136.90.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $109.72 on Friday. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.14. Addus HomeCare Corporation has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The firm has a 50-day simple moving average of $113.11 and a 200 day simple moving average of $113.42. The company has a market cap of $2.03 billion, a PE ratio of 23.49, a P/E/G ratio of 1.35 and a beta of 0.92.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 3rd. The company reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.53 by $0.03. The firm had revenue of $362.30 million for the quarter, compared to analysts’ expectations of $354.48 million. Addus HomeCare had a net margin of 6.36% and a return on equity of 9.53%. Addus HomeCare’s revenue was up 25.0% on a year-over-year basis. During the same quarter last year, the company posted $1.30 earnings per share. On average, sell-side analysts anticipate that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Insider Buying and Selling

In other Addus HomeCare news, EVP Darby Anderson sold 20,000 shares of the stock in a transaction on Wednesday, November 19th. The stock was sold at an average price of $109.00, for a total value of $2,180,000.00. Following the sale, the executive vice president directly owned 44,144 shares of the company’s stock, valued at $4,811,696. This trade represents a 31.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In the last ninety days, insiders sold 20,316 shares of company stock worth $2,215,998. 4.50% of the stock is owned by corporate insiders.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.